Skip to main content

Advertisement

Log in

Vitamin D receptor and estrogen receptor gene polymorphisms in men with type 2 diabetes: Effects on Bone Metabolism

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Purpose

There is an increased fracture risk in type 2 diabetes mellitus [DM] patients independent of bone mineral density [BMD], both in men and women. Estrogen receptor [ER]-alpha and vitamin D receptor [VDR] gene polymorphisms may predispose patients to increased osteoporosis and fracture risk. This study aims to analyze the relationship of the ER-alpha gene and VDR gene polymorphisms with indicators of bone turnover and BMD in male type 2 diabetic patients.

Methods

Type 2 diabetic men diagnosed with diabetes for at least one year and healthy controls were included in this cross-sectional study. BMD was measured by dual X ray absorptiometry. Gene polymorphisms were evaluated with polymerase chain reaction-restriction length polymorphism. Serum iPTH, calcium, beta-CrossLaps (cTx), osteocalcin, and free testosterone levels were also evaluated.

Results

Participants were 141 type 2 diabetic men [55 ± 8 years] and 100 healthy controls [53 ± 7 years]. BMD measurements were not statistically different between the groups. While iPTH [p < 0.05] and serum calcium levels [p = 0.03] were higher in men with type 2 DM; beta-CrossLaps [p = 0.0001], osteocalcin [p = 0.005], and free testosterone [p = 0.04] were lower than controls. The differences in terms of the frequencies of VDR Apa, Taq, Bsm, Fok and ER-alpha polymorphisms were not statistically significant between the groups. No relationship was observed between polymorphisms and BMD in both groups.

Conclusions

VDR and ER-alpha gene polymorphisms seem to have no effect on BMD and bone turnover in men with DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49:863–71.

    Article  CAS  PubMed  Google Scholar 

  2. Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA. Bone mineral density of both genders in Type 1 diabetes according to bone composition. J Diabetes Complications. 2006;20:302–7.

    Article  PubMed  Google Scholar 

  3. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab. 2006;91:3404–10.

    Article  CAS  PubMed  Google Scholar 

  4. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res. 2002;58:266–72.

    CAS  PubMed  Google Scholar 

  5. Alexopoulou O, Jamart J, Devogelaer JP, Brichard S, de Nayer P, Buysschaert M. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab. 2006;32:453–8.

    Article  CAS  PubMed  Google Scholar 

  6. Xu L, Cheng M, Liu X, Shan P, Gao H. Bone mineral density and its related factors in elderly male Chinese patients with type 2 diabetes. Arch Med Res. 2007;38:259–64.

    Article  PubMed  Google Scholar 

  7. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007;18:427–44.

    Article  CAS  PubMed  Google Scholar 

  8. Parfitt AM. Genetic effects on bone mass and turnover-relevance to black/white differences. J Am Coll Nutr. 1997;16:325–33.

    Article  CAS  PubMed  Google Scholar 

  9. Ma X, Jing Y, Qin W, Chai X, Xu J, Zhou T, Yang J. Vitamin D receptor gene polymorphism and bone mineral density in patients with type 2 diabetes mellitus. Chin Med J [Engl] 2001; 114: 1213–1215.

  10. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41:1314–20.

    Article  CAS  PubMed  Google Scholar 

  11. Duman BS, Tanakol R, Erensoy N, Ozturk M, Yilmazer S. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women.

  12. Med Princ. Pract. 2004;13:260–5.

    Google Scholar 

  13. Nam HS, Shin MH, Kweon SS, Park KS, Sohn SJ, Rhee JA, Choi JS, Son MH. Association of estrogen receptor-alpha gene polymorphisms with bone mineral density in postmenopausal Korean women. J Bone Miner Metab. 2005;23:84–9.

    Article  CAS  PubMed  Google Scholar 

  14. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, Mavilia C, Del Monte F, Melton LJ 3rd, Brandi ML. Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab. 2004;89:1808–16.

    Article  CAS  PubMed  Google Scholar 

  15. Lenchik L, Hsu FC, Register TC, Lohman KK, Freedman BI, Langefeld CD, et al Bowden DW, Carr JJ. Heritability of spinal trabecular volumetric bone mineral density measured by QCT in the Diabetes Heart Study. Calcif Tissue Int. 2004;75:305–12.

    Article  CAS  PubMed  Google Scholar 

  16. Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, Wolkow P, Skupien J, Bobrek J, Czogala M, Klupa T, Sieradzki J. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol. 2006;43:114–9.

    Article  CAS  PubMed  Google Scholar 

  17. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Bone mineral density is not sensitive enough to assess the risk of vertebral fractures intype 2 diabetic women. Calcif Tissue Int. 2007;80:353–8.

    Article  CAS  PubMed  Google Scholar 

  18. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications. J Bone Miner Res. 2009;24:702–9.

    Article  CAS  PubMed  Google Scholar 

  19. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495–505.

    Article  PubMed  Google Scholar 

  20. Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus. Endocr J. 2011;58:613–24.

    Article  CAS  PubMed  Google Scholar 

  21. Gogas Yavuz D, Keskin L, Kıyıcı S, Sert M, Yazıcı D, Sahin I, Yüksel M, Deyneli O, Aydın H, Tuncel E, Akalın S. Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetic patients. Acta Diabetol. 2011;48:329–36.

    Article  PubMed  Google Scholar 

  22. Reyes-García R, Rozas-Moreno P, López-Gallardo G, García-Martín A, Varsavsky M, Avilés-Perez MD, Munos-Torres M. Serum levels of bone resorption markers are decreased in patients with type 2 diabetes. Acta Diabetol. 2011;50:47–52.

    Article  PubMed  Google Scholar 

  23. Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV, Cauley JA, Zmuda JM, Hoffman AR, Ensrud KE. Osteoporotic Fractures in Men [MrOs] Study Group. Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res. 2010;25:285–91.

    Article  PubMed  Google Scholar 

  24. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010;39:419–46.

    Article  CAS  PubMed  Google Scholar 

  25. Mohammadi Z, Fayyazbakhsh F, Ebrahimi M, Amoli MM, Khashayar M, Dini M, Zadeh RN, Keshtkar A, Barikani HR. Association between vitamin D receptor gene polymorphisms [Fok1 and Bsm1] and osteoporosis: a systematic review. J Diabetes Metabolic Disorders. 2014;13:98.

    Article  Google Scholar 

  26. Dilmec F, Uzer E, Akkafa F, Kose E, van Kuilenburg AB. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J Diabetes Complications. 2010;24:186–91.

    Article  PubMed  Google Scholar 

  27. Rivera-Leon EA, Palmeros-Sanchez B, Llamas-Covarrubias IM, Fernandez S, Armendariz-Borunda J, Gonzalez-Hita M, Bastidas-Ramirez BE, Zepeda-Moreno A, Sanchez-Enriquez S. Vitamin-D receptor gene polymorphisms [TaqI and ApaI] and circulating osteocalcin in patients with type 2 diabetes and healthy subjects. Endokrynol Pol. 2015;66:329–33.

    Article  PubMed  Google Scholar 

  28. Kocabaş A, Karagüzel G, İmir N, Yavuzer U, Akçurin S. Effects of Vitamin D Receptor Gene Polymorphisms on Susceptibility to Disease and Bone Mineral Density in Turkish Patients with Type 1 Diabetes Mellitus. J Pediatr Endocrinol Metab. 2010;23:1289–97.

    Article  PubMed  Google Scholar 

  29. Hauache OM, Lazaretti-Castro M, Andreoni S, Gimeno SG, Brandão C, Ramalho AC, Kasamatsu TS, Kunii I, Hayashi LF, Dib SA, Vieira JG. Vitamin D Receptor Gene Polymorphism: Correlation With Bone Mineral Density in a Brazilian Population With Insulin-Dependent Diabetes Mellitus. Osteoporos Int. 1998;8:204–10.

    Article  CAS  PubMed  Google Scholar 

  30. Meshkani R, Saberi H, Mohammadtaghvaei N, Tabatabaiefar MA. Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects. Mol Cell Biochem. 2012;359:225–33.

    Article  CAS  PubMed  Google Scholar 

  31. Koh JM, Kim DJ, Hong JS, Park JY, Lee KU, Kim SY, Kim GS. Estrogen receptor a gene polymorphisms [PvuII and XbaI] influence association between leptin receptor gene polymorphism [Gln223Arg] and bone mineral density in young men. Eur J Endocrinol. 2002;147:777–83.

    Article  CAS  PubMed  Google Scholar 

  32. Langdahl BL, Løkke E, Carstens M, Stenkjær LL, Erıksen EF. A TA repeat polymorphism in the estrogen receptor gene ıs associated with osteoporotic fractures but polymorphisms in the first exon and ıntron are not. J B Miner Res. 2000;25:2222–30.

    Article  Google Scholar 

  33. Huang Q, Wang Q, Zhang L, Lu J, Zhou Q, Liu Y, He J, Lin F. Relationship between bone mineral density and polymorphism of the estrogen receptor gene in healthy postmenopausal women in China Chin Med J [Engl] 1999;112: 832–835.

  34. Wongdee K, Krishnamra N. Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption. J Physiol Sci. 2017;67:71–81., Charoenphandhu N.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dilek Yazıcı.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yavuz, D.G., Yüksel, M., Sancak, S. et al. Vitamin D receptor and estrogen receptor gene polymorphisms in men with type 2 diabetes: Effects on Bone Metabolism. J Diabetes Metab Disord 21, 1293–1299 (2022). https://doi.org/10.1007/s40200-022-01048-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-022-01048-6

Keywords

Navigation